@ascletisp
ID: 1589465332758052864
calendar_today07-11-2022 03:51:52
124 Tweet
14 Takipçi
0 Takip Edilen
a year ago
Ascletis Announces Dosing of the First Patient in Phase III Clinical Trial of ASC40 (Denifanstat) for Treatment of Acne ascletis.com/news_detail/18…